Literature DB >> 30558843

Elimination of HIV transmission through novel and established prevention strategies among people who inject drugs.

Hudson Reddon1, Brandon D L Marshall2, M-J Milloy3.   

Abstract

Despite the effectiveness of existing HIV prevention strategies for people who inject drugs (PWID), uncontrolled outbreaks of HIV among this group are common and occur around the world. In this Review, we summarise recent evidence for novel and established HIV prevention approaches to eliminate HIV transmission among PWID. Effective HIV prevention strategies include mobile needle and syringe programmes, pre-exposure prophylaxis, supervised injection facilities, and, to a lesser extent, some behavioural interventions. Studies have also shown the cost-effectiveness of long-standing HIV prevention strategies including needle and syringe programmes, opioid agonist therapy, and antiretroviral therapy for prevention. Although each individual intervention can reduce the risk of HIV acquisition among PWID, there is a consensus that a combination of approaches is required to achieve substantial and durable reductions in HIV transmission. Unfortunately, in many settings, the implementation of these interventions is often limited by public and political opposition that manifests as structural barriers to HIV prevention, such as the criminalisation of drug use. Given that there is ample evidence showing the effectiveness of several HIV prevention methods, social and political advocacy will be needed to overcome these barriers and integrate innovative HIV prevention approaches with addiction science to create effective drug policies.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 30558843      PMCID: PMC6599632          DOI: 10.1016/S2352-3018(18)30292-3

Source DB:  PubMed          Journal:  Lancet HIV        ISSN: 2352-3018            Impact factor:   12.767


  14 in total

Review 1.  Opioid and chemokine regulation of cortical synaptodendritic damage in HIV-associated neurocognitive disorders.

Authors:  Bradley Nash; Lindsay Festa; Chihyang Lin; Olimpia Meucci
Journal:  Brain Res       Date:  2019-08-26       Impact factor: 3.252

2.  HCV communication within ego-centric networks of men and women who inject drugs.

Authors:  Marisa Felsher; Karin E Tobin; Mark Sulkowski; Carl Latkin; Oluwaseun Falade-Nwulia
Journal:  Drug Alcohol Depend       Date:  2021-10-29       Impact factor: 4.492

3.  Ending the HIV Epidemic Among Persons Who Inject Drugs: A Cost-Effectiveness Analysis in Six US Cities.

Authors:  Emanuel Krebs; Xiao Zang; Benjamin Enns; Jeong E Min; Czarina N Behrends; Carlos Del Rio; Julia C Dombrowski; Daniel J Feaster; Kelly A Gebo; Brandon D L Marshall; Shruti H Mehta; Lisa R Metsch; Ankur Pandya; Bruce R Schackman; Steffanie A Strathdee; Bohdan Nosyk
Journal:  J Infect Dis       Date:  2020-09-02       Impact factor: 5.226

4.  Global patterns of opioid use and dependence: harms to populations, interventions, and future action.

Authors:  Louisa Degenhardt; Jason Grebely; Jack Stone; Matthew Hickman; Peter Vickerman; Brandon D L Marshall; Julie Bruneau; Frederick L Altice; Graeme Henderson; Afarin Rahimi-Movaghar; Sarah Larney
Journal:  Lancet       Date:  2019-10-23       Impact factor: 79.321

5.  Pre-exposure prophylaxis awareness, acceptability and potential stigma among medical and non-medical clinic staff in methadone treatment settings in northern New Jersey: The key role of non-medical staff in enhancing HIV prevention.

Authors:  J Jaiswal; K Dunlap; M Griffin; A Cox; S N Singer; K Hascher; C LoSchiavo; S M Walters; M Mumba
Journal:  J Subst Abuse Treat       Date:  2021-03-17

6.  Injection and sexual risk among people who use or inject drugs in Kampala, Uganda: An exploratory qualitative study.

Authors:  Julia Dickson-Gomez; Wamala Twaibu; Erica Christenson; Katende Dan; Ronald Anguzu; Ethan Homedi; Nazarius Mbona Tumwesigye
Journal:  PLoS One       Date:  2020-04-22       Impact factor: 3.240

Review 7.  Responding to global stimulant use: challenges and opportunities.

Authors:  Michael Farrell; Natasha K Martin; Emily Stockings; Annick Bórquez; Javier A Cepeda; Louisa Degenhardt; Robert Ali; Lucy Thi Tran; Jürgen Rehm; Marta Torrens; Steve Shoptaw; Rebecca McKetin
Journal:  Lancet       Date:  2019-10-23       Impact factor: 79.321

8.  A randomized controlled trial of a brief behavioral intervention to reduce skin and soft tissue infections among people who inject drugs.

Authors:  Kristina T Phillips; Catherine Stewart; Bradley J Anderson; Jane M Liebschutz; Debra S Herman; Michael D Stein
Journal:  Drug Alcohol Depend       Date:  2021-02-27       Impact factor: 4.492

9.  Factors Associated with Likelihood of Initiating Others into Injection Drug Use Among People Who Inject Drugs in West Virginia.

Authors:  Sean T Allen; Kristin E Schneider; Alyona Mazhnaya; Rebecca Hamilton White; Allison O'Rourke; Alex H Kral; Ricky N Bluthenthal; Michael E Kilkenny; Susan G Sherman
Journal:  AIDS Behav       Date:  2021-06-02

10.  Drug use stigma and its association with active hepatitis C virus infection and injection drug use behaviors among community-based people who inject drugs in India.

Authors:  Eshan U Patel; Sunil S Solomon; Gregory M Lucas; Allison M McFall; Cecília Tomori; Aylur K Srikrishnan; Muniratnam S Kumar; Oliver Laeyendecker; David D Celentano; David L Thomas; Thomas C Quinn; Shruti H Mehta
Journal:  Int J Drug Policy       Date:  2021-07-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.